Results 231 to 240 of about 112,428 (350)

Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges

BMEMat, EarlyView.
This figure illustrates various material strategies for neurovascularized bone regeneration, including electroactive scaffolds, ion‐loaded materials, drug delivery systems, surface modifications, cells/cell products, growth factors, and peptides. These approaches aim to synergistically promote the regeneration of neural, vascular, and bone tissues ...
Yixin Ma, Nan Jiang, Liyuan Chen, He Zhang, Xinjia Cai, Karan Gulati, Danqing He, Zhigang Cai, Yan Liu   +8 more
wiley   +1 more source

New Insights Into the Human Dopamine Transporter: Structure, Function, and Therapeutic Potential. [PDF]

MedComm (2020)
Weng Q, Wu Q, Zheng Q.
europepmc   +1 more source

Extending the Family: Roles for Uptake\u3csub\u3e2\u3c/sub\u3e Transporters in Regulation of Monoaminergic Signaling [PDF]

, 2017
Daws, Lynette C., Gasser, Paul J.
core   +1 more source

Dual sigma receptor/dopamine transporter inhibition and the union of pharmacology and experimental psychology

Jordan Katz
openalex   +2 more sources

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Distinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT). [PDF]

Pharmaceuticals (Basel)
Farías-Cea A, Pérez L, Leal C, Segura K, Hernández V, Atiés-Pérez C, Martínez LM, Hödar-Salazar M, Reyes-Parada M, Sotomayor-Zárate R, Rojas-Hidalgo F, Julio-Pieper M, Bravo JA, Borroto-Escuela DO, Iturriaga-Vásquez P.   +14 more
europepmc   +1 more source

Synthesis of iodinated 3β-aryltropanes with selective binding to either the dopamine or serotonin transporters

, 2002
Huw M. L. Davies, Pingda Ren, Norman Kong, Tammy Sexton, Steven R. Childers   +4 more
openalex   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

The radiotracer [¹²³I]I-FP-CIT binds preferentially to the dopamine transporter expressed at the plasma membrane of nigrostriatal dopaminergic neurons: a new concept. [PDF]

Ann Nucl Med
Booij J, Chahid Y, Reits EA, Gether U.
europepmc   +1 more source

Dopamine Transporter Changes in Neuropsychiatric Disorders

, 1997
Dean F. Wong, G.A. Ricaurte, Gerhard Gründer, Richard E. Rothman, S. Naidu, Harvey S. Singer, James C. Harris, Fuji Yokoi, Victor L. Villemagne, S. Szymanski, Albert Gjedde, M. Kuhad   +11 more
openalex   +1 more source